- Home
- AWX vs NLSP Comparison
AWX vs NLSP Comparison
Compare AWX & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AWX
- NLSP
- Stock Information
- Founded
- AWX 1998
- NLSP 2015
- Country
- AWX United States
- NLSP Switzerland
- Employees
- AWX N/A
- NLSP N/A
- Industry
- AWX Environmental Services
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- AWX Utilities
- NLSP Health Care
- Exchange
- AWX Nasdaq
- NLSP Nasdaq
- Market Cap
- AWX 9.9M
- NLSP 243.8M
- IPO Year
- AWX 1998
- NLSP 2021
- Fundamental
- Price
- AWX $2.68
- NLSP $4.55
- Analyst Decision
- AWX
- NLSP
- Analyst Count
- AWX 0
- NLSP 0
- Target Price
- AWX N/A
- NLSP N/A
- AVG Volume (30 Days)
- AWX 2.7K
- NLSP 33.1K
- Earning Date
- AWX 11-07-2024
- NLSP 11-01-2024
- Dividend Yield
- AWX N/A
- NLSP N/A
- EPS Growth
- AWX N/A
- NLSP N/A
- EPS
- AWX 0.01
- NLSP N/A
- Revenue
- AWX $83,149,000.00
- NLSP N/A
- Revenue This Year
- AWX N/A
- NLSP N/A
- Revenue Next Year
- AWX N/A
- NLSP N/A
- P/E Ratio
- AWX $362.75
- NLSP N/A
- Revenue Growth
- AWX N/A
- NLSP N/A
- 52 Week Low
- AWX $1.90
- NLSP $4.08
- 52 Week High
- AWX $2.75
- NLSP $29.84
- Technical
- Relative Strength Index (RSI)
- AWX 56.11
- NLSP 40.59
- Support Level
- AWX $2.67
- NLSP $4.38
- Resistance Level
- AWX $2.75
- NLSP $5.64
- Average True Range (ATR)
- AWX 0.04
- NLSP 0.47
- MACD
- AWX 0.00
- NLSP 0.06
- Stochastic Oscillator
- AWX 67.39
- NLSP 29.16
About AWX Avalon Holdings Corporation
Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.